Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Obesity and CYP2C19[original query] |
---|
Clinical pharmacokinetics and pharmacodynamics of clopidogrel. Clinical pharmacokinetics 2015 Feb 54 (2): 147-66. Jiang Xi-Ling, Samant Snehal, Lesko Lawrence J, Schmidt Steph |
Influence of genetic co-factors on the population pharmacokinetic model for clopidogrel and its active thiol metabolite. European journal of clinical pharmacology 2017 Sep . Danielak Dorota, Kara?niewicz-?ada Marta, Komosa Anna, Burchardt Pawe?, Lesiak Maciej, Kruszyna ?ukasz, Graczyk-Szuster Agnieszka, G?ówka Francisz |
[Genetic and non-genetic factors of laboratory resistance to clopidogrel in patients with ischemic stroke]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2019 119 (3. Vyp. 2): 45-52. Sychev D A, Shprakh V V, Kitaeva E Yu, Mirzaev K B, Mickhalevich I |
Impact of body mass index on efficacy and safety of ticagrelor versus clopidogrel in patients with minor stroke or transient ischemic attack. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2023 7 195 (26): E897-E904. Jia Zhang, Anxin Wang, Xue Tian, Xia Meng, Xuewei Xie, Jing Jing, Jinxi Lin, Yilong Wang, Zixiao Li, Liping Liu, Hao Li, Yong Jiang, Xingquan Zhao, Yongjun Wa |
Utility of the ACD-GENE-CLI Score in Asian Patients with Critical Limb Ischemia Undergoing Endovascular Interventions. Journal of atherosclerosis and thrombosis 2023 12 . Wei-Ting Chang, Po-Sen Huang, Li-Wei Su, Chia-Te Liao, Han Siong Toh, Yi-Chen Chen, Chung-Han Ho, Zhih-Cherng Chen, Po-Chao Hsu, Chon-Seng Ho |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: